BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36234908)

  • 1. Synthesis, Molecular Docking Study, and Cytotoxicity Evaluation of Some Novel 1,3,4-Thiadiazole as Well as 1,3-Thiazole Derivatives Bearing a Pyridine Moiety.
    Abouzied AS; Al-Humaidi JY; Bazaid AS; Qanash H; Binsaleh NK; Alamri A; Ibrahim SM; Gomha SM
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Molecular Docking of Some Novel Thiazoles and Thiadiazoles Incorporating Pyranochromene Moiety as Potent Anticancer Agents.
    Gomha SM; Abdelhamid AO; Kandil OM; Kandeel SM; Abdelrehem NA
    Mini Rev Med Chem; 2018; 18(19):1670-1682. PubMed ID: 29692239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and cytotoxicity evaluation of some novel thiazoles, thiadiazoles, and pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5(1H)-ones incorporating triazole moiety.
    Gomha SM; Ahmed SA; Abdelhamid AO
    Molecules; 2015 Jan; 20(1):1357-76. PubMed ID: 25594346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A facile access and evaluation of some novel thiazole and 1,3,4-thiadiazole derivatives incorporating thiazole moiety as potent anticancer agents.
    Gomha SM; Abdelaziz MR; Kheder NA; Abdel-Aziz HM; Alterary S; Mabkhot YN
    Chem Cent J; 2017 Oct; 11(1):105. PubMed ID: 29086869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Anticancer Evaluation of New Thiazole and Thiadiazole Derivatives Bearing Acetanilide Moiety.
    El-Rayyes A; Soliman AM; Saeed A
    Russ J Gen Chem; 2022; 92(10):2132-2144. PubMed ID: 36408422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of adamantane scaffold containing 1,3,4-thiadiazole derivatives: Design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR.
    Wassel MMS; Ammar YA; Elhag Ali GAM; Belal A; Mehany ABM; Ragab A
    Bioorg Chem; 2021 May; 110():104794. PubMed ID: 33735711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents.
    Dawood KM; Eldebss TM; El-Zahabi HS; Yousef MH; Metz P
    Eur J Med Chem; 2013; 70():740-9. PubMed ID: 24231309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Molecular Docking Screening and Anti-Proliferative Potency Evaluation of Some New Imidazo[2,1-
    Rashdan HRM; Abdelmonsef AH; Shehadi IA; Gomha SM; Soliman AMM; Mahmoud HK
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33126630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-(Thiophen-2-yl)-1,3,4-thiadiazole derivatives: synthesis, molecular docking and in vitro cytotoxicity evaluation as potential anticancer agents.
    Gomha SM; Edrees MM; Muhammad ZA; El-Reedy AA
    Drug Des Devel Ther; 2018; 12():1511-1523. PubMed ID: 29881258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazole-Based Thiosemicarbazones: Synthesis, Cytotoxicity Evaluation and Molecular Docking Study.
    Gomha SM; Abdelhady HA; Hassain DZH; Abdelmonsef AH; El-Naggar M; Elaasser MM; Mahmoud HK
    Drug Des Devel Ther; 2021; 15():659-677. PubMed ID: 33633443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
    Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
    Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-Pot Synthesis of Novel Thiazoles as Potential Anti-Cancer Agents.
    Sayed AR; Gomha SM; Taher EA; Muhammad ZA; El-Seedi HR; Gaber HM; Ahmed MM
    Drug Des Devel Ther; 2020; 14():1363-1375. PubMed ID: 32308369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR Study of the Novel Thiadiazole-Imidazole Derivatives as a New Anticancer Agents.
    Gomha SM; Abdel-Aziz HM; Khalil KD
    Chem Pharm Bull (Tokyo); 2016; 64(9):1356-63. PubMed ID: 27581640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Characterization and Molecular Docking of Novel Bioactive Thiazolyl-Thiazole Derivatives as Promising Cytotoxic Antitumor Drug.
    Gomha SM; Salaheldin TA; Hassaneen HM; Abdel-Aziz HM; Khedr MA
    Molecules; 2015 Dec; 21(1):E3. PubMed ID: 26703554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Some New 1,3,4-Thiadiazole, Thiazole and Pyridine Derivatives Containing 1,2,3-Triazole Moiety.
    Abdelriheem NA; Mohamed AM; Abdelhamid AO
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28208643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, Molecular Docking Study and Anti-Hepatocellular Carcinoma Evaluation of New Bis-Triazolothiadiazines.
    Gomha SM; Muhammad ZA; Ezz El-Arab E; Elmetwally AM; El-Sayed AA; Matar IK
    Mini Rev Med Chem; 2020; 20(9):788-800. PubMed ID: 31613728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and efficient approach for synthesis of novel bioactive [1,3,4]thiadiazoles incorporated with 1,3-thiazole moiety.
    Farghaly TA; Abdallah MA; Masaret GS; Muhammad ZA
    Eur J Med Chem; 2015 Jun; 97():320-33. PubMed ID: 26055810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents.
    Hafez HN; El-Gazzar ABA
    Curr Org Synth; 2020; 17(1):55-64. PubMed ID: 32103718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Thiophenyl Thiazolyl-Pyridine Hybrids as Potential Anticancer Agents.
    Ashmawy FO; Gomha SM; Abdallah MA; Zaki MEA; Al-Hussain SA; El-Desouky MA
    Molecules; 2023 May; 28(11):. PubMed ID: 37298747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights.
    Al-Warhi T; El Kerdawy AM; Said MA; Albohy A; Elsayed ZM; Aljaeed N; Elkaeed EB; Eldehna WM; Abdel-Aziz HA; Abdelmoaz MA
    Drug Des Devel Ther; 2022; 16():1457-1471. PubMed ID: 35607598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.